IL4 and rhinitis: Treatment of HNECs with IL-4 and IL-13, which are highly concentrated in the nasal epithelium of rhinitis patients, decreases the expression of ZO-1 and Occludin, components of tight junctions (Supplementary Figs. 4A and B) [28].